26 results
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
was the Executive Vice President and Chief Financial Officer of Exelixis, Inc., a biotechnology company. During his tenure at Exelixis, Mr. Karbe was responsible
8-K
EX-99.1
uvwmqw
2 Nov 22
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
5:07pm
424B3
jy06tv
13 Jun 22
Prospectus supplement
4:31pm
8-K
heh8t7adejqp0vq5prc
13 Jun 22
Departure of Directors or Certain Officers
8:52am
DEF 14A
sxnfdluv8p0zghpi5
27 Apr 22
Definitive proxy
12:37pm
424B3
9x1os
7 Apr 22
Prospectus supplement
4:08pm
POS AM
bvx62rtr21ux nf
1 Apr 22
Prospectus update (post-effective amendment)
4:25pm
424B3
glbuwz xucwaudf0
10 Dec 21
Prospectus supplement
6:06am
8-K
EX-3.2
v38g1
3 Nov 21
Unaudited Pro Forma Condensed Combined Financial Statements
5:26pm
424B3
6cs 159u3v
12 Oct 21
Prospectus supplement
5:13pm